Exception From Informed Consent: 7 Keys to EFIC Study Success

Exception From Informed Consent (EFIC) studies have a distinct and challenging set of regulatory guidelines. While 21 CFR 50.24 provides the regulatory framework for EFIC studies in the US, implementing these regulations in practice is not straightforward. Pharma Initiatives has experience successfully assisting our clients through the EFIC planning and execution process. In this one hour webinar, Pharma Initiatives Partners Gary Tyson and Mark Shapiro will share seven keys to success based on their experience. This will be an interactive webinar with time for questions.